News Data on trial of anticoagulant is to be reanalyzed after discovery that investigators used faulty device BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h6431 (Published 03 December 2015) Cite this as: BMJ 2015;351:h6431 Article Related content Metrics Responses Peer review Related articles Editorial Safety of new oral anticoagulants Published: 24 April 2015; BMJ 350 doi:10.1136/bmj.h1679 See more US abortion restrictions are keeping brain dead pregnant woman on life support BMJ May 30, 2025, 389 r1120; DOI: https://doi.org/10.1136/bmj.r1120 FDA approves blood test to diagnose Alzheimer’s BMJ May 23, 2025, 389 r1082; DOI: https://doi.org/10.1136/bmj.r1082 Will RFK Jr really Make America Healthy Again? BMJ May 15, 2025, 389 r871; DOI: https://doi.org/10.1136/bmj.r871 Trump turns government’s covid websites into pages promoting lab leak claims BMJ April 23, 2025, 389 r806; DOI: https://doi.org/10.1136/bmj.r806 Trump watch: Leaked plan to slash NIH budget in half, CDC contradicts RFK Jr on autism, and more BMJ April 23, 2025, 389 r798; DOI: https://doi.org/10.1136/bmj.r798 Cited by... Direct oral anticoagulants versus warfarin: is new always better than the old?Abstract Fulltext PDF Cochrane corner: self-monitoring and self-management of oral anticoagulationAbstract Fulltext PDF Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial FibrillationAbstract Fulltext PDF